The incretin effect accounts for 5070% of your entire insulin response to a meal
Rapid improvements in blood sugar control may worsen diabetic retinopathy in some patients, requiring extra attention for those with preexisting eye conditions
SLC25A39 knockout in A549 and H1299 cells significantly decreased the expression of HEY1, HES1, and NOTCH1 (Fig
Other GLP1 receptor agonists, such as Trulicity (dulaglutide), Wegovy (also semaglutide but at a higher dose for weight loss), and Victoza (liraglutide), offer similar mechanisms but vary in dosing frequency, cost, and clinical indications
Currently, its only available through clinical trials